The first commercially available Vasopressin RIA
Vasopressin
Anti-diuretic hormone (ADH), or [Arg8]-Vasopressin (AVP), is a peptide hormone produced by the hypothalamus and stored in the posterior part of pituitary gland. ADH acts on kidneys, concentrating urine by promoting the re-absorption of water from the cortical collecting duct.
Decreased ADH release leads to diabetes insipidus, a condition featuring hypernatremia (increased blood sodium content), pollyuria (excess urine production) and thirst.
Raised ADH levels (Syndrome of Inappropriate Antidiuretic Hormone or SIADH), and the resulting hyponatremia, occurs in diseases of the brain and lung. In the perioperative period, the effects of surgical stress and some commonly used medications (e.g. opiates, syntocinon, anti-emetics) lead to a similar state of excess ADH secretion. This may cause mild hyponatremia for several days.
Vasopressin direct RIA
Role in disease:
• Decreased ADH leads to diabetes insipidus, a condition featuring hypernatremia (increased blood sodium content), polyuria (excess urine production) and thirst.
• Raised ADH (syndrome of inappropriate antidiuretic hormone, SIADH) and resultant hyponatremia occurs in brain diseases and conditions of the lungs. In the peri-operative period, the effects of surgical stress and some commonly used medications lead to a similar state of excess ADH secretion. This may cause mild hyponatremia for several days.
| Advantages of the BUHLMANN VASOPRESSIN RIA: | |
|---|---|
|
Sensitivity: |
1.25 pg/ml |
|
Specificity: |
<0.001% cross-reactivity with Oxytocin |
|
Reproducibility: |
pre-measured standards and two controls |
Product Information
| Vasopressin | Vasopressin Direct | |
|---|---|---|
Method |
125I-RIA | 125I-RIA |
Time to results |
48 h | 48 h |
Sample Type |
1 ml EDTA plasma & urine | 0.8 ml EDTA plasma |
Standard range |
0.63-80 pg/ml | 1.25-80 pg/ml |
Sensitivity |
0.4 pg/ml | 0.75 pg/ml |
Order Code |
RK- AR1 100 tests | RK- VPD 100 tests |
| CE | CE |
| DOWNLOADS | ||||
|---|---|---|---|---|
Instruction
|
Instruction
|
Technical information |
Labelling schedule |
|
English |
[PDF 0.4MB] | [PDF 0.3MB] | [PDF 0.7MB] | 2013 [PDF 150 KB] |
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
| Distributors Order About us Job opportunities |
Search
News
Calprotectin ELISA Automation
BÜHLMANN has set a focus on automation of its ELISA tests, starting with Calprotectin. A number of validated protocols are available on the commonly use more
Interviews from Dr. Christoph Noppen (Viollier, Allschwil) about the EGFR test from EntroGen and from Dr. Günter Dollenmaier (ZLMSG) about the Anyplex II RV16 test from Seegene
Please read the two new success stories with our new products. You will find the interview with Dr. Christoph Noppen about the evaluation of the EGFR Rea more
Interviews on calprotectin by BÜHLMANN on the National Health channel UK
TV programme on calprotectin diagnosis for IBD and BÜHLMANN Laboratories on the NHS National Health Channel in the UK. The interviews are scheduled to be more
BÜHLMANN releases a new calprotectin test
CALcheck Blue™ is a rapid qualitative screening test. Easy to use, with Quick Prep extraction, no pipetting, no vortexing , reaction time of 10 minutes to more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |